Opiate Substitution Treatment

• 

  Subject Areas on Research

  • "Choose Physical Therapy" for Neonatal Abstinence Syndrome: Clinical Management for Infants Affected by the Opioid Crisis. 
  • A mixed methods study of provider factors in buprenorphine treatment retention. 
  • A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. 
  • Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. 
  • Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. 
  • Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration. 
  • Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. 
  • Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. 
  • Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network. 
  • Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. 
  • Criminal justice continuum for opioid users at risk of overdose. 
  • Digital ischaemia after intra-arterial drug injection. 
  • Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers. 
  • Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina. 
  • Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder. 
  • HIV, prisoners, and human rights. 
  • Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder. 
  • Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care. 
  • Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder. 
  • Influence of HIV antiretrovirals on methadone N-demethylation and transport. 
  • Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study. 
  • MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions. 
  • Medication-Based Treatment to Address Opioid Use Disorder. 
  • Opioid Management in Pregnancy and Postpartum. 
  • Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial. 
  • Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C). 
  • Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone. 
  • Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program. 
  • Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality. 
  • Problem drinking and low-dose naltrexone-assisted opioid detoxification. 
  • Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. 
  • Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models. 
  • Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report. 
  • Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. 
  • Tales from the frontlines: An alarming rise in hospitalizations related to opioid use disorder in the era of COVID-19. 
  • The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal. 
  • The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints. 
  • Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018. 
  • Treatment preference for opioid use disorder among people who are incarcerated. 
  • Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014. 
  • What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. 
• 

  Keywords of People

  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine